132 related articles for article (PubMed ID: 15052374)
1. Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas.
Banyai A; Varga L; Barta A; Gopcsa L; Paloczi K
Cancer Immunol Immunother; 2004 Sep; 53(9):835-9. PubMed ID: 15052374
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of serum complement components and plasma C3d in patients with malignant lymphoma: relation to the stage of the tumor and circulating immune complexes.
Heier HE; Carpentier NA; Lambert PH; Godal T
Int J Cancer; 1978 Jun; 21(6):695-9. PubMed ID: 669852
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of C3 and C4 in patients with immune complexes and normal complement levels.
Charlesworth JA; Peake PW; Golding J; Pussell BA; Timmermans V; Wicks I; Wakefield D
Aust N Z J Med; 1989 Apr; 19(2):118-24. PubMed ID: 2764813
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
5. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
[TBL] [Abstract][Full Text] [Related]
6. Complement systems C4, C3 and CH50 not subject to a circadian rhythm.
Lung T; Matozan K; Risch M; Sakem B; Nydegger UE; Risch L
Diagnosis (Berl); 2018 Jun; 5(2):77-82. PubMed ID: 29813028
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma levels of complement in patients with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Atanasiu AN; Petrescu AM; Mitu AC; Iliescu I; Dumitrescu L
Rom J Intern Med; 2008; 46(1):77-80. PubMed ID: 19157274
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes, complement factors C3, C4, C1-inhibitor, alpha-1-antitrypsin and immunoglobulins in asthmatic patients.
Häfner GE; Wüthrich B; Grob PJ; Arrenbrecht S
Respiration; 1981; 41(4):248-57. PubMed ID: 6975491
[TBL] [Abstract][Full Text] [Related]
9. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
10. BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients.
Visani G; Malerba L; Stefani PM; Capria S; Galieni P; Gaudio F; Specchia G; Meloni G; Gherlinzoni F; Giardini C; Falcioni S; Cuberli F; Gobbi M; Sarina B; Santoro A; Ferrara F; Rocchi M; Ocio EM; Caballero MD; Isidori A
Blood; 2011 Sep; 118(12):3419-25. PubMed ID: 21816830
[TBL] [Abstract][Full Text] [Related]
11. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
[TBL] [Abstract][Full Text] [Related]
12. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of diabetic patients with periodontitis.
Anil S; Remani P; Vijayakumar T; Joseph PA
J Periodontol; 1990 Jan; 61(1):27-9. PubMed ID: 2107297
[TBL] [Abstract][Full Text] [Related]
13. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
Larsson A; Sjöquist J
J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
[TBL] [Abstract][Full Text] [Related]
14. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
[TBL] [Abstract][Full Text] [Related]
15. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
[TBL] [Abstract][Full Text] [Related]
16. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
Garred P; Michaelsen TE; Aase A; Mollnes TE
J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
[TBL] [Abstract][Full Text] [Related]
17. Studies of monkey complement: measurement of cynomolgus monkey CH50, ACH50, C4, C2 and C3.
Xu H; Kitano E; Sato Y; Kobayashi C; Firdawes S; Kitamura H; Fukuzawa M; Miyagawa S
Xenotransplantation; 2008 Feb; 15(1):14-9. PubMed ID: 18333909
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract][Full Text] [Related]
20. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
